Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.

Morning Session - FDA

• FDA Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee (AM Session)
• Errata to the FDA Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee

Amgen Inc.

• Amgen Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee
• Errata to the Amgen Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee

Afternoon Session - FDA

• FDA Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee (PM Session)

Mylan GmbH

• Mylan Briefing Information for the July 13, 2017 Meeting of the Oncologic Drugs Advisory Committee